QOL Medical LLC
Lisa Winebrenner is a seasoned sales specialist in the rare disease sector, currently serving at QOL Medical LLC since July 2021. Previous roles include Territory Sales Manager at Coram CVS/Specialty Infusion Services and Specialty Sales Representative at Amgen, where significant accomplishments included ranking a territory as the #6 in the country for sales within six months. Experience also includes a Clinical Sales Liaison position at Briova Rx Infusion, focusing on enhancing patient care for infusion and specialty drugs, and a Clinical Sales Specialist role at Roche Diagnostics, where strategic relationships were built to drive market share for diabetes management products. Lisa Winebrenner is also the former owner of Priority 1 Consulting Company, providing various consulting services, and worked as a Cardiovascular Nurse Consultant at Touchpoint Solutions. Additionally, Lisa Winebrenner held the role of Nurse Manager at The University of Kansas Hospital. Lisa Winebrenner holds an Executive MBA from Benedictine College.
This person is not in any offices
QOL Medical LLC
OL Medical is a specialty biopharmaceutical company dedicated to improving the quality of life for patients with rare diseases, for their families, and for the physicians and caregivers who support them.QOL Medical is a patient-centric company founded in 2003 to focus on the acquisition and commercialization of orphan products in underservedmarkets. QOL Medical ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of rare and orphan diseases. The Company currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (Ethanolamine Oleate) Injection, 5%.QOL Medical, in its commitment to assuring safe and effective products for our customers, uses validated procedures through audited and approved vendors for manufacturing, testing, and distribution. Additionally, QOL Medical has procedures for product monitoring, customer complaints, investigations into nonconformities, and change control.